未接种疫苗孕妇在Delta和Omicron变异株流行期间SARS-CoV-2感染的母婴结局
这项回顾性队列研究纳入土耳其和英国两家三级中心的1286例未接种疫苗的孕期SARS-CoV-2感染孕妇,比较pre-Delta、Delta和Omicron三个时期的结局。经混杂因素平衡后,Delta期较pre-Delta期需鼻导管吸氧、CPAP或高流量氧、机械通气和ECMO的风险均升高,孕产妇死亡率也更高(5.3% vs 1.5%);Omicron期与pre-Delta期需氧支持及死亡率相似。Delta期早产(<34周)显著增加。
要点
- Delta期感染较pre-Delta期需机械通气RR 4.20、ECMO RR 11.0,孕产妇死亡率5.3% vs 1.5%。
- Omicron期需鼻导管吸氧较Delta期显著降低(RR 0.26),但与pre-Delta期相似。
- Delta期早产(<34周)15.4% vs pre-Delta期4.9%,差异显著。
核心结论
- 未接种疫苗孕妇在Delta期感染SARS-CoV-2较pre-Delta期需氧支持(含ECMO)增加且孕产妇死亡率更高,Omicron期疾病严重程度与妊娠并发症与pre-Delta期相似;无论变异株如何,未接种疫苗孕妇感染均带来相当高的病残和死亡风险,接种疫苗仍是关键。
研究设计与样本
- 回顾性队列研究,纳入土耳其Sancaktepe培训与研究医院和英国圣乔治大学医院NHS基金会信托两家三级中心2020年4月1日至2022年2月14日RT-PCR确诊的1286例未接种疫苗孕期SARS-CoV-2感染孕妇,按阳性检测日期分为pre-Delta(870例)、Delta(339例)和Omicron(77例)三组,采用进化搜索算法平衡混杂因素(母亲年龄、BMI、诊断时孕周)。
诊断标准与关键数值
- 主要结局为需氧支持,分类为鼻导管或面罩吸氧、CPAP或高流量氧无创机械通气、插管机械通气或ECMO。
- Delta期 vs pre-Delta期:鼻导管吸氧RR 2.53(95%CI 1.75-3.65,P<0.001),CPAP或高流量氧RR 2.50(95%CI 1.37-4.56,P=0.002),机械通气RR 4.20(95%CI 1.60-11.0,P=0.003),ECMO RR 11.0(95%CI 1.43-84.7,P=0.021)。
- 孕产妇死亡率Delta期5.3% vs pre-Delta期1.5%(P=0.010),Delta期较pre-Delta期高3.6倍。
- Omicron期 vs pre-Delta期:鼻导管吸氧RR 0.62(95%CI 0.25-1.55,P=0.251),CPAP或高流量氧RR 1.07(95%CI 0.36-3.12,P=0.906),机械通气RR 0.44(95%CI 0.06-3.45,P=0.438),孕产妇死亡率1.3% vs 1.3%(P=0.999)。
- Omicron期 vs Delta期:鼻导管吸氧RR 0.26(95%CI 0.11-0.64,P=0.003),Omicron期显著低于Delta期。
临床应用与阅片要点
- 作者结论指出,未接种疫苗孕妇感染SARS-CoV-2无论变异株均带来相当高的病残和死亡风险,接种疫苗仍是关键。
- 作者指出,对Omicron感染风险的错误传播可能对孕妇疫苗接种意愿产生不利影响,而孕妇是SARS-CoV-2相关并发症的高危人群。
局限性
- 围产结局仅在一部分混杂因素平衡队列中可获得。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: There is little evidence related to the effects of the Omicron severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant on pregnancy outcomes, particularly in unvaccinated women. This study aimed to compare pregnancy outcomes of unvaccinated women infected with SARS-CoV-2 during the pre-Delta, Delta and Omicron waves.
METHODS: This was a retrospective cohort study conducted at two tertiary care facilities: Sancaktepe Training and Research Hospital, Istanbul, Turkey, and St George's University Hospitals NHS Foundation Trust, London, UK. Included were women who tested positive for SARS-CoV-2 by real-time reverse-transcription polymerase chain reaction (RT-PCR) during pregnancy, between 1 April 2020 and 14 February 2022. The cohort was divided into three periods according to the date of their positive RT-PCR test: (i) pre-Delta (1 April 2020 to 8 June 2021 in Turkey, and 1 April 2020 to 31 July 2021 in the UK), (ii) Delta (9 June 2021 to 27 December 2021 in Turkey, and 1 August 2021 to 27 December 2021 in the UK) and (iii) Omicron (after 27 December 2021 in both Turkey and the UK). Baseline data collected included maternal age, parity, body mass index, gestational age at diagnosis and comorbidities. The primary outcome was the need for oxygen supplementation, classified as oxygen support via nasal cannula or breather mask, non-invasive mechanical ventilation with continuous positive airway pressure (CPAP) or high-flow oxygen, mechanical ventilation with intubation, or extracorporeal membrane oxygenation (ECMO). Inferences were made after balancing of confounders, using an evolutionary search algorithm. Selected confounders were maternal age, body mass index and gestational age at diagnosis of infection.
RESULTS: During the study period, 1286 unvaccinated pregnant women with RT-PCR-proven SARS-CoV-2 infection were identified, comprising 870 cases during the pre-Delta period, 339 during the Delta wave and 77 during the Omicron wave. In the confounder-balanced cohort, infection during the Delta wave vs during the pre-Delta period was associated with increased need for nasal oxygen support (risk ratio (RR), 2.53 (95% CI, 1.75-3.65); P < 0.001), CPAP or high-flow oxygen (RR, 2.50 (95% CI, 1.37-4.56); P = 0.002), mechanical ventilation (RR, 4.20 (95% CI, 1.60-11.0); P = 0.003) and ECMO (RR, 11.0 (95% CI, 1.43-84.7); P = 0.021). The maternal mortality rate was 3.6-fold higher during the Delta wave compared to the pre-Delta period (5.3% vs 1.5%, P = 0.010). Infection during the Omicron wave was associated with a similar need for nasal oxygen support (RR, 0.62 (95% CI, 0.25-1.55); P = 0.251), CPAP or high-flow oxygen (RR, 1.07 (95% CI, 0.36-3.12); P = 0.906) and mechanical ventilation (RR, 0.44 (95% CI, 0.06-3.45); P = 0.438) with that in the pre-Delta period. The maternal mortality rate was similar during the Omicron wave and the pre-Delta period (1.3% vs 1.3%, P = 0.999). The need for nasal oxygen support during the Omicron wave was significantly lower compared to the Delta wave (RR, 0.26 (95% CI, 0.11-0.64); P = 0.003). Perinatal outcomes were available for a subset of the confounder-balanced cohort. Preterm birth before 34 weeks' gestation was significantly increased during the Delta wave compared with the pre-Delta period (15.4% vs 4.9%, P < 0.001).
CONCLUSIONS: Among unvaccinated pregnant women, SARS-CoV-2 infection during the Delta wave, in comparison to the pre-Delta period, was associated with increased requirement for oxygen support (including ECMO) and higher maternal mortality. Disease severity and pregnancy complications were similar between the Omicron wave and pre-Delta period. SARS-CoV-2 infection of unvaccinated pregnant women carries considerable risks of morbidity and mortality regardless of variant, and vaccination remains key. Miscommunication of the risks of Omicron infection may impact adversely vaccination uptake among pregnant women, who are at increased risk of complications related to SARS-CoV-2. © 2022 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Birol Ilter P, Prasad S, Mutlu MA, et al. Maternal and perinatal outcomes of SARS-CoV-2 infection in unvaccinated pregnancies during Delta and Omicron waves. Ultrasound Obstet Gynecol. 2022. PMID: 35441407. doi:10.1002/uog.24916
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。